FeesSafety
Pluang+

XAI Octagon Floating Rate Trust upgraded from sell to hold after tender offer ends, yield at 15.85%.

Market News
24 Oct 2026
Seeking Alpha
View Source
Neutral
XAI Octagon Floating Rate Trust upgraded from sell to hold after tender offer ends, yield at 15.85%.

The recommendation for the XAI Octagon Floating Rate & Alternative Income Trust (XFLT) has been raised from sell to hold following the expiration of its tender offer. The fund, which offers a high yield of 15.85%, experienced a 13.4% decline in its net asset value year-to-date, but the recent tender offer is seen as a positive event. Investors are advised to hold the fund to monitor the effects of the tender offer and any future corporate actions before making further investment decisions.

The XAI Octagon Floating Rate & Alternative Income Trust (XFLT) tender offering deadline has expired, with the fund now rated hold. For readers following Financials-sector stocks, here is Pluang's market snapshot as of Oct 24, 2026 14:01 WIB: out of 142 priced US stocks, 21 rose and 119 fell. Notable movers include XP Inc. Class A Common Stock at USD 30.41 (+3.61%), Blue Owl Capital Inc. Class A Common Stock at USD 9.36 (-3.60%) with 100% buy order activity, and Lufax Holding Ltd at USD 8.08 (-3.58%).

More News

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...

Others
Neutral
56 minutes ago
Darolutamide with ADT and radiation cuts metastasis or death risk by 58% in high-risk prostate cancer patients.

Darolutamide with ADT and radiation cuts metastasis or death risk by 58% in high-risk prostate cancer patients.

Interim results from the Phase 3 DASL-HiCaP trial show that adding darolutamide to standard androgen deprivation therapy (ADT) and radiation therapy reduces the risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence...

Company Fundamentals
Bullish
3 hours ago
Anthropic's revenue jumps to $16.3B in H1 2026, up from $1.1B last year

Anthropic's revenue jumps to $16.3B in H1 2026, up from $1.1B last year

Anthropic reported a massive increase in revenue, reaching $16.3 billion in the first half of 2026 compared to just $1.1 billion in the same period last year. This surge highlights rapid growth and strong demand for its products or services. The dram...

Market News
Bullish
4 hours ago
NEAR Protocol leads crypto losses with an 8.93% drop amid broader market declines

NEAR Protocol leads crypto losses with an 8.93% drop amid broader market declines

NEAR Protocol (NEAR) experienced the largest 24-hour decline among major cryptocurrencies, falling 8.93% to $4.47. Other notable drops included Bitcoin down 1.28% to $80,495, Ether down 1.38% to $2,360.57, and XRP down 3.45% to $1.28. These declines ...

Market News
Bearish
4 hours ago
XRP's 2017-18 rally gains estimated between 62,000% and 119,000%, varying by measurement methods.

XRP's 2017-18 rally gains estimated between 62,000% and 119,000%, varying by measurement methods.

Estimates of XRP's price rally during 2017-18 vary widely, from about 62,000% to 119,000%, depending on different starting prices and measurement periods. Vandell Aljarrah of Black Swan Capitalist highlighted a 630-fold rise when XRP moved above a tr...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App